Jordan Chan
@JordanSFChan
Followers
103
Following
799
Media
11
Statuses
85
PhD Candidate @JussherLab @UAlberta - Faculty of Pharmacy and Pharmaceutical Sciences
Edmonton, Alberta
Joined April 2022
RT @LabSpiegelman: The passing Of Dave Mangelsdorf is a terrible loss for his family, friends and the science world. Davo will never be for….
0
28
0
RT @CellPressNews: Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Read the f….
cell.com
GLP-1R agonists may reduce cardiometabolic complications in part through reduction of inflammation. Here we show, using pharmacology and genetics, that the anti-inflammatory actions of GLP-1RAs to...
0
16
0
RT @NatMetabolism: RESEARCH | @LoganTownsend86, @DrGregSteinberg et. al. (@MacMODR). #Anxiety -like behaviour in mice, as a result of psych….
nature.com
Nature Metabolism - Anxiety-like behaviour in mice, as a result of psychological stress, is shown to be mediated by GDF15 release in response to adipose tissue lipolysis.
0
19
0
RT @CircRes: @KaitDennis19 et al found #FoxO1-zDHHC4-#CD36 S-acylation axis drives metabolic dysfunction in #diabetes. Learn more at https:….
0
5
0
RT @Heatherlab_ox: 🚨New from our group in @CircRes .We identify a FoxO1-zDHHC4-CD36 S-acylation axis driving metabolic + contractile dysfun….
ahajournals.org
BACKGROUND: The fatty acid (FA) transporter CD36 (FA translocase/cluster of differentiation 36) is the gatekeeper of cardiac FA metabolism. Preferential localisation of CD36 to the sarcolemma is one...
0
8
0
Same spot, 3 days later, after an amazing conference and…a best ECI presentation award! Thank you again @ishr2025 @QKarwi for the opportunity to present some of my research in the @JussherLab. Had a great time reconnecting with old colleagues and getting to meet some new ones!
1
0
6
RT @dunjaaks: Grateful to @JussherLab Jordan SF Chan & @AmDiabetesAssn for featuring our T2D cardiomyopathy model in their editorial.Of Mi….
diabetesjournals.org
It is becoming increasingly recognized that diabetic cardiomyopathy (DbCM) is often prevalent in individuals with pre- or early-stage type 2 diabetes (T2D)
0
5
0
RT @DanielJDrucker: Here it is proposed that halofuginone, a FDA–approved anti-scleroderma and antiprotozoal drug, is a promising anti-#ob….
science.org
Halofuginone curbs weight gain in mice and pigs.
0
8
0
Thank you for going easy on me 🙏.
A big CONGRATS to @JordanSFChan , who successfully passed his #CandidacyExam this morning! Really proud seeing how much he has matured as a #scientist since joining the lab May 2021
2
1
9
RT @JussherLab: So this Monday was the 10 year #anniversary of the lab (time flies!!) and a very eventful week, starting with a presentatio….
0
2
0
RT @SaedChristina: Happy for my labmatte @Amurtab .Congratulations 👏 🎉 you worked hard and you deserve it!.
0
1
0
RT @UAlberta_Pharm: New anti-obesity drug shows promise in preventing heart failure related to Type 2 diabetes. John Ussher finds experime….
0
5
0
RT @SaedChristina: It’s been an incredible journey completing my PhD at @JussherLab . Excited to start my postdoc at @DrGregSteinberg lab!….
0
1
0
RT @QKarwi: 🎉Excited to share our new review @mole_biochem discussing how energy metabolism controls the inflammatory responses and functio….
0
3
0
RT @ExpPhysiol: 🥇🎉🥇.Congratulations to @JussherLab, the winner of our 2024 #MidCareerResearcher prize! Ussher's review will focus on the Mu….
0
7
0
RT @JEndocrinology: Read the latest review in the #Incretins Special Collection:.📍 Incretin-mediated control of cardiac energy metabolism.B….
0
4
0
RT @janicekung: ICYMI: New article by @JussherLab Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experiment….
pubmed.ncbi.nlm.nih.gov
Growth differentiation factor 15 (GDF15) is a peptide with utility in obesity, as it decreases appetite and promotes weight loss. Because obesity increases the risk for type 2 diabetes (T2D) and...
0
1
0
RT @janicekung: Kudos to @JussherLab & @JordanSFChan for latest review paper, Incretin-mediated control of cardiac energy metabolism https:….
pubmed.ncbi.nlm.nih.gov
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like-peptide-1 (GLP-1) are incretin hormones that stimulate insulin secretion and improve glycemic control in individuals with type 2...
0
1
0
RT @Soc_HrtVasMetab: 👏Following on in the Monday 9/09 am session will be University of Alberta Professor and Canadian Research Chair in Pha….
0
3
0